dc.contributor.author | Shamash, J | en_US |
dc.contributor.author | Sarker, S-J | en_US |
dc.date.accessioned | 2016-01-06T13:18:00Z | |
dc.date.issued | 2014-01-07 | en_US |
dc.date.submitted | 2016-01-05T18:43:17.509Z | |
dc.identifier.issn | 0007-0920 | en_US |
dc.identifier.other | 0007-0920 | |
dc.identifier.other | 10.1038/bjc.2013.736 | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/10336 | |
dc.description | This work is licensed under the Creative Commons
Attribution-NonCommercial-Share Alike 3.0 Unported
License. | en_US |
dc.format.extent | 266 - 267 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | BRITISH JOURNAL OF CANCER | en_US |
dc.title | Comment on 'Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer' | en_US |
dc.type | Article | |
dc.rights.holder | © 2014. Cancer Research UK | |
dc.identifier.doi | 10.1038/bjc.2013.736 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000329493700035&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 1 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 110 | en_US |